annual EBIT:
-$247.39M-$98.73M(-66.41%)Summary
- As of today (June 25, 2025), AKRO annual earnings before interest & taxes is -$247.39 million, with the most recent change of -$98.73 million (-66.41%) on December 31, 2024.
- During the last 3 years, AKRO annual EBIT has fallen by -$146.62 million (-145.48%).
- AKRO annual EBIT is now -1695.56% below its all-time high of -$13.78 million, reached on December 31, 2018.
Performance
AKRO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$69.57M-$747.00K(-1.09%)Summary
- As of today (June 25, 2025), AKRO quarterly earnings before interest & taxes is -$69.57 million, with the most recent change of -$747.00 thousand (-1.09%) on March 31, 2025.
- Over the past year, AKRO quarterly EBIT has dropped by -$17.22 million (-32.89%).
- AKRO quarterly EBIT is now -16425.18% below its all-time high of -$421.00 thousand, reached on March 31, 2018.
Performance
AKRO quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$264.61M-$17.22M(-6.96%)Summary
- As of today (June 25, 2025), AKRO TTM earnings before interest & taxes is -$264.61 million, with the most recent change of -$17.22 million (-6.96%) on March 31, 2025.
- Over the past year, AKRO TTM EBIT has dropped by -$88.97 million (-50.66%).
- AKRO TTM EBIT is now -62752.73% below its all-time high of -$421.00 thousand, reached on March 31, 2018.
Performance
AKRO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AKRO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -66.4% | -32.9% | -50.7% |
| 3 y3 years | -145.5% | -167.3% | -136.9% |
| 5 y5 years | -441.9% | -462.0% | -403.9% |
AKRO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -145.5% | at low | -206.5% | +2.6% | -140.3% | at low |
| 5 y | 5-year | -441.9% | at low | -462.0% | +2.6% | -403.9% | at low |
| alltime | all time | -1695.6% | at low | <-9999.0% | +2.6% | <-9999.0% | at low |
AKRO EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$69.57M(+1.1%) | -$264.61M(+7.0%) |
| Dec 2024 | -$247.39M(+66.4%) | -$68.82M(-3.7%) | -$247.39M(+6.2%) |
| Sep 2024 | - | -$71.46M(+30.5%) | -$232.86M(+16.3%) |
| Jun 2024 | - | -$54.76M(+4.6%) | -$200.17M(+14.0%) |
| Mar 2024 | - | -$52.35M(-3.6%) | -$175.64M(+18.1%) |
| Dec 2023 | -$148.66M(+33.6%) | -$54.29M(+40.0%) | -$148.66M(+27.0%) |
| Sep 2023 | - | -$38.77M(+28.3%) | -$117.07M(+3.1%) |
| Jun 2023 | - | -$30.23M(+19.1%) | -$113.52M(+2.6%) |
| Mar 2023 | - | -$25.37M(+11.8%) | -$110.64M(-0.6%) |
| Dec 2022 | -$111.29M(+10.4%) | -$22.70M(-35.6%) | -$111.29M(-8.0%) |
| Sep 2022 | - | -$35.22M(+28.8%) | -$121.02M(+9.9%) |
| Jun 2022 | - | -$27.35M(+5.1%) | -$110.13M(-1.4%) |
| Mar 2022 | - | -$26.03M(-19.7%) | -$111.72M(+10.8%) |
| Dec 2021 | -$100.78M | -$32.42M(+33.3%) | -$100.81M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$24.33M(-15.9%) | -$98.17M(+2.9%) |
| Jun 2021 | - | -$28.93M(+91.3%) | -$95.38M(+15.1%) |
| Mar 2021 | - | -$15.13M(-49.2%) | -$82.90M(+3.4%) |
| Dec 2020 | -$80.15M(+75.6%) | -$29.78M(+38.3%) | -$80.15M(+20.4%) |
| Sep 2020 | - | -$21.54M(+30.9%) | -$66.59M(+8.5%) |
| Jun 2020 | - | -$16.45M(+32.9%) | -$61.36M(+16.8%) |
| Mar 2020 | - | -$12.38M(-23.7%) | -$52.52M(+15.0%) |
| Dec 2019 | -$45.65M(+231.3%) | -$16.22M(-0.5%) | -$45.65M(+40.9%) |
| Sep 2019 | - | -$16.31M(+114.3%) | -$32.40M(+81.8%) |
| Jun 2019 | - | -$7.61M(+38.0%) | -$17.82M(-5.6%) |
| Mar 2019 | - | -$5.51M(+85.7%) | -$18.87M(+37.0%) |
| Dec 2018 | -$13.78M | -$2.97M(+71.9%) | -$13.78M(+27.5%) |
| Sep 2018 | - | -$1.73M(-80.1%) | -$10.81M(+19.0%) |
| Jun 2018 | - | -$8.66M(+1957.5%) | -$9.08M(+2057.5%) |
| Mar 2018 | - | -$421.00K | -$421.00K |
FAQ
- What is Akero Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Akero Therapeutics?
- What is Akero Therapeutics annual EBIT year-on-year change?
- What is Akero Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Akero Therapeutics?
- What is Akero Therapeutics quarterly EBIT year-on-year change?
- What is Akero Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Akero Therapeutics?
- What is Akero Therapeutics TTM EBIT year-on-year change?
What is Akero Therapeutics annual earnings before interest & taxes?
The current annual EBIT of AKRO is -$247.39M
What is the all time high annual EBIT for Akero Therapeutics?
Akero Therapeutics all-time high annual earnings before interest & taxes is -$13.78M
What is Akero Therapeutics annual EBIT year-on-year change?
Over the past year, AKRO annual earnings before interest & taxes has changed by -$98.73M (-66.41%)
What is Akero Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of AKRO is -$69.57M
What is the all time high quarterly EBIT for Akero Therapeutics?
Akero Therapeutics all-time high quarterly earnings before interest & taxes is -$421.00K
What is Akero Therapeutics quarterly EBIT year-on-year change?
Over the past year, AKRO quarterly earnings before interest & taxes has changed by -$17.22M (-32.89%)
What is Akero Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of AKRO is -$264.61M
What is the all time high TTM EBIT for Akero Therapeutics?
Akero Therapeutics all-time high TTM earnings before interest & taxes is -$421.00K
What is Akero Therapeutics TTM EBIT year-on-year change?
Over the past year, AKRO TTM earnings before interest & taxes has changed by -$88.97M (-50.66%)